|
|
Other links at Articles > Pharmacists |
| 2. |
High-Dose Epirubicin for Breast Cancer Provides No Overall Benefit
|
|
|
High-dose epirubicin with cyclophosphamide provides longer event-free survival than does a low-dose approach as adjuvant chemotherapy for node-positive breast cancer. However, the regimen is more cardiotoxic than is standard oral cyclophosphamide, methotrexate, and fluorouracil (CMF) and the outcome is not superior, according to European researchers. Reuters Health Information
|
| 3. |
Warfarin-Induced Skin Necrosis
|
|
|
Warfarin-induced skin necrosis is a rare and potentially life-threatening complication of warfarin therapy. This case report explores the challenges of dealing with vitamin K antagonist therapy. Southern Medical Journal
|
|
|
